|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2002-11-4
|
|
pubmed:abstractText |
In patients with congestive heart failure (CHF), clinical trials have demonstrated the benefit of a number of drugs on morbidity and mortality. Nevertheless so far, there is no published controlled study of long-term antithrombotic therapy in patients with CHF. The aim of this work was to identify the relationship between cardiovascular drug use, especially antithrombotic therapy, and survival of CHF patients in current clinical practice, using an observational, population-based database.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1388-9842
|
|
pubmed:author |
pubmed-author:AdmantPhP,
pubmed-author:AliotEE,
pubmed-author:AllamSS,
pubmed-author:AlliNN,
pubmed-author:BailleNN,
pubmed-author:BellangerPhP,
pubmed-author:BretonChCh,
pubmed-author:BriançonSS,
pubmed-author:D'HôtelRR,
pubmed-author:DambrinePP,
pubmed-author:Delahaye,
pubmed-author:DodetJ FJF,
pubmed-author:DucimetièrePP,
pubmed-author:EPICAL Investigators. Epidémiologie de l'Insuffisance Cardiaque Avancée...,
pubmed-author:EchemannMM,
pubmed-author:FagnaniFF,
pubmed-author:GrailleMM,
pubmed-author:GuizeLL,
pubmed-author:JuillièreYY,
pubmed-author:KesslerMM,
pubmed-author:KhalifaWW,
pubmed-author:MertèsP MPM,
pubmed-author:NeimannJ LJL,
pubmed-author:RebeixGG,
pubmed-author:Royer,
pubmed-author:SaulnierJ PJP,
pubmed-author:ThisseJ YJY,
pubmed-author:TruttBB,
pubmed-author:VidalPhP,
pubmed-author:VillemotJ PJP,
pubmed-author:VirionJ MJM,
pubmed-author:VuilleminM ChMCh,
pubmed-author:ZannadFF
|
|
pubmed:copyrightInfo |
Copyright 2002 European Society of Cardiology
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
647-54
|
|
pubmed:dateRevised |
2011-6-8
|
|
pubmed:meshHeading |
pubmed-meshheading:12413509-Adrenergic beta-Antagonists,
pubmed-meshheading:12413509-Adult,
pubmed-meshheading:12413509-Aged,
pubmed-meshheading:12413509-Aged, 80 and over,
pubmed-meshheading:12413509-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:12413509-Anticoagulants,
pubmed-meshheading:12413509-Aspirin,
pubmed-meshheading:12413509-Controlled Clinical Trials as Topic,
pubmed-meshheading:12413509-Databases, Factual,
pubmed-meshheading:12413509-Dose-Response Relationship, Drug,
pubmed-meshheading:12413509-Female,
pubmed-meshheading:12413509-Fibrinolytic Agents,
pubmed-meshheading:12413509-Follow-Up Studies,
pubmed-meshheading:12413509-France,
pubmed-meshheading:12413509-Heart Failure,
pubmed-meshheading:12413509-Humans,
pubmed-meshheading:12413509-Hypolipidemic Agents,
pubmed-meshheading:12413509-Male,
pubmed-meshheading:12413509-Middle Aged,
pubmed-meshheading:12413509-Prospective Studies,
pubmed-meshheading:12413509-Severity of Illness Index,
pubmed-meshheading:12413509-Survival Analysis,
pubmed-meshheading:12413509-Systole,
pubmed-meshheading:12413509-Treatment Outcome,
pubmed-meshheading:12413509-Ventricular Dysfunction, Left
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study).
|
|
pubmed:affiliation |
Service d'Epidémiologie et d'Evaluation cliniques, Hôpital Marin, CHU Nancy, France.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
